DrStockPick.com Stock Report!

Tuesday September 15, 2009

**************************************************************

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus. LX4211 is an orally-delivered, small molecule drug candidate that inhibits the sodium glucose transporter 2 (SGLT2). LX4211 is Lexicon’s fourth drug candidate currently being tested in Phase 2 clinical trials.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT), the world’s leading developer of medical devices, announced today the presentation of new pre-clinical research findings from their Huntington’s disease program at the 2009 World Congress on Huntington’s Disease held September 12-15, 2009 in Vancouver, British Columbia. Together, the two companies are developing a drug-device combination for the treatment of Huntington’s disease. The drug, ALN-HTT, consists of an RNAi therapeutic targeting huntingtin, the gene responsible for Huntington’s disease, and is delivered to the central nervous system (CNS) using an implantable pump infusion system developed by Medtronic.

eBay (Nasdaq:EBAY), the world’s largest online marketplace and leading U.S. destination for clothing, shoes and accessories, today announced plans with designer Narciso Rodriguez to introduce an original eight-piece capsule collection to be sold exclusively through the Narciso Rodriguez eBay Store beginning in Spring 2010. The collection, to be called Narciso Rodriguez for eBay, will offer style makers worldwide high-quality designer fashion and redefines how and where savvy shoppers buy designer brand name clothing at accessible prices.

eMagin Corporation (OTCBB:EMAN), the leader in OLED technology for the design and manufacture of OLED microdisplays for high resolution imaging products, today announced that it entered into an agreement for a line of credit as of September 1, 2009, pursuant to which the Company may borrow up to $3 million. eMagin obtained the credit facility from Access Business Finance, LLC in order to provide an additional source of financing of its capital program, if needed.

V7, the exclusive house brand for Ingram Micro Inc. (NYSE: IM) and provider of premier computer accessories worldwide, today announced its latest mice, keyboards and keyboard/mouse combinations for value-added resellers, small-to-medium businesses (SMBs) and systems integrators in the U.S.

Green Energy Live (OTCBB: GELV) today announced that the acquisition of Comanche Livestock Exchange, LLC (CLEL), a privately-owned Texas-based provider of live animal auctions, was closed on July 24, 2009, with the delivery of restricted common stock shares and a promissory note. CLEL will be a wholly-owned subsidiary.

***********Advertisement***********

********************************

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) .Rule 17B requires disclosure of payment for investor relations.

Last 5 posts by Dr. Stock Pick

• DrStockPick.com Stock Report! Wednesday Nov 25, 2009 (Upgrades/Downgrades) - November 25th, 2009
• CVAT, Cavitation Technologies Filed Three New PCT Patent Applications - Grass Roots Research Initiates Coverage With $2.04 Price Target - November 25th, 2009
• PSFT, PowerSafe Announces Its Selection by NASA for Two Small Business Innovation Research Projects - November 25th, 2009
• DrStockPick.com Stock Report! 11/25/09, STM, CSRH, HLIT, SOLF, OBAS, CIMT - November 25th, 2009
• PWRM, INCY, DrStockPick.com Stock Report! Power 3 Medical Products Inc. and Incyte Corp - November 25th, 2009